Method for increasing neutrophil populations using in vitro-derived human neutrophil precursor cells
Patent Number: 5888499
Date of First Priority Issue: Monday March 23rd, 1992
Date Issued: Tuesday March 30th, 1999
Assignee: Nexell Therapeutics Inc. (Irvine, CA)
Inventors: Bender, James G. (Lindenhurst, IL); Maples, Phillip B. (Waukegan, IL); Smith, Stephen (Arlington Heights, IL); Unverzagt, Kristen L. (Palatine, IL); Van Epps, Dennis E. (Cary, IL)
From Class: Use
Comments: No comments
This patent covers ways of generating neutrophil-committed stem cells. These neutrophil committed stem cells are useful for prevention of infection after myeloablation.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.